BioLineRx Ltd. announced a private placement of 6,835,206 common shares at a price of $2.136 per share for the gross proceeds of $14.6 million on August 30, 2023. The closing of transactions is contingent upon approval by Israeli innovation authority of license agreement within four months of execution, and other closing conditions.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.7 ILa | -0.60% | -1.76% | -56.28% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.28% | 52.51M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.79% | 22.15B | |
-17.37% | 21.02B | |
-8.17% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- BLRX Stock
- News BioLineRx Ltd.
- BioLineRx Ltd. announced that it expects to receive $14.6 million in funding